Trials / Completed
CompletedNCT06614257
REduced Pain After Bariatric Surgery - Gastric Bypass
REduced Pain After Bariatric Surgery - Gastric Bypass (REPABS-BPG)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to analyze the effect of laparoscopic guided transversus abdominis plane (LG-TAP) block compared to placebo for postoperative analgesia following laparoscopic gastric bypass. One group of participants received a (LG-TAP) block with local anesthetic while the other group received (LG-TAP) block with saline solution (placebo).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LG-TAP block with local anesthetic | The laparoscopic guided TAP Block was performed by surgeon at the beginning of surgery, injecting 15 ml of Ropivacaine 0.5% on each side, using an atraumatic needle (10/15 cm length, 20 Gauge diameter) close to the anterior axillary line, between the iliac crest and the subcostal margin. Correct needle tip positioning between the transverse muscle of the abdomen and the internal oblique was verified through laparoscopic guidance. |
| PROCEDURE | Port site infiltration | Prior the surgical incision, an infiltration of the laparoscopic access using a total of 10 ml Ropivacaine 0.5% was performed by surgeon |
| DRUG | LG-TAP block with saline solution | The laparoscopic guided TAP Block was performed by surgeon at the beginning of surgery, injecting 15 ml of Saline solution (NaCl 0.9%) on each side, using an atraumatic needle (10/15 cm length, 20 Gauge diameter) close to the anterior axillary line, between the iliac crest and the subcostal margin. Correct needle tip positioning between the transverse muscle of the abdomen and the internal oblique was verified through laparoscopic guidance. |
Timeline
- Start date
- 2022-01-04
- Primary completion
- 2024-03-03
- Completion
- 2024-03-08
- First posted
- 2024-09-26
- Last updated
- 2024-09-26
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06614257. Inclusion in this directory is not an endorsement.